SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-10-187319
Filing Date
2010-08-12
Accepted
2010-08-12 16:39:55
Documents
10
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 433391
2 PATENT ASSIGNMENT AND LICENSE AGREEMENT, DATED MAY 21, 2008 dex101.htm EX-10.1 104446
3 AMENDMENT NO. 1, DATED OCTOBER 9, 2008 dex102.htm EX-10.2 10470
4 AMENDMENT NO. 2, DATED JUNE 18, 2009 dex103.htm EX-10.3 33942
5 AMENDMENT NO. 3 DATED JUNE 4, 2010 dex104.htm EX-10.4 34042
6 FIRST AMENDMENT, DATED AS OF JANUARY 29, 2009 dex105.htm EX-10.5 21220
7 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 6762
8 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 6742
9 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3949
10 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3922
  Complete submission text file 0001193125-10-187319.txt   660469
Mailing Address 3830 MONTE VILLA PARKWAY BOTHELL WA 98021
Business Address 3830 MONTE VILLA PARKWAY BOTHELL WA 98021 4259083600
Marina Biotech, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-13789 | Film No.: 101011586
SIC: 2834 Pharmaceutical Preparations